ChAd63-PvDBP vaccine (University of Oxford)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameChAd63-PvDBP vaccine (University of Oxford)
Drug Alias NameChAd63 PvDBP
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMalaria, VivaxMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Oxford
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Oxford
Inactive CompaniesN/A
Active IndicationsMalaria, Vivax
Inactive IndicationsMalaria

Other Information

ATC CodeN/A
Related LinksN/A